Clinical trials registries: Towards improved access to therapeutic data

Prescrire International

Volumn 17, Issue 98, 2008, Pages 256-259

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

ACCESS TO INFORMATION; ARTICLE; CLINICAL RESEARCH; CLINICAL TRIAL; COMPUTER INTERFACE; DRUG INDUSTRY; EUROPE; HUMAN; INFORMED CONSENT; MEDICAL ETHICS; ONLINE SYSTEM; PUBLICATION; REGISTRATION; SEARCH ENGINE; STANDARDIZATION; UNITED STATES; WORLD HEALTH ORGANIZATION;

ACCESS TO INFORMATION; CLINICAL TRIALS AS TOPIC; DATABASES AS TOPIC; DATABASES, FACTUAL; DRUG INDUSTRY; EUROPE; HUMANS; INFORMATION DISSEMINATION; INTERNATIONAL COOPERATION; MANDATORY REPORTING; PERIODICALS AS TOPIC; PUBLISHING; REGISTRIES; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION; WORLD HEALTH ORGANIZATION;

EID: 57349103346     PISSN: 11677422     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Simes RJ "Publication bias: the case for an international registry of clinical trials" J Clin Oncol 1986; 4 (10): 1529-1541.
2. De Angelis CD et al. "Is this clinical trial fully registered? A statement from the International Committee of Medical Journal Editors" JAMA 2005; 291 (23): 2927-2929.
3. Council of Science Editors "CSE Endorsement of Principles: ICMJE's Statement on Clinical Trial Registration" 14 April 2006. www.councilscienceeditors. org accessed 8 March 2008: 2 pages.
4. World Association of Medical Editors "WAME Policy Statements. The Registration of Clinical Trials" 22 July 2005. www.wame.org/ resources/policies #trialreg accessed 18 March 2008: 1 page.
5. Gulmezoglu AM et al. "WHO facilitates international collaboration in setting standards for clinical trial registration" Lancet 2005; 365: 1829-1831.
6. The Ottawa Group "Draft - The Ottawa Statement, Part Two: Principles of operationalisation for international trial registration" 6 January 2006. ottawagroup.ohri.ca accessed 25 February 2008: 6 pages.
7. Sim I et al. "Clinical trial registration: transparency is the watchword" Lancet 2006; 367: 1631-1633.
8. U.S. Public Law 110-85 "Food and Drug Administration Amendments Act of 2007. Tire VIII - Clinical Trials databases" 27 September 2007: 22 pages.
9. NIH "Fact Sheet. Registration at ClinicalTrials.gov: as required by Public Law 110-85, Title VIII" 9 November 2007. prsinfo.clinicaltrials.gov accessed 2 March 2008: 5 pages.
10. Drazen JM et al. "Open clinical trials" N Engl J Med 2007; 357 (17): 1756-1757.
11. Laine C et al. "Clinical trial registration: looking back and moving ahead" Ann Int Med 2007; 147 (4): 275-277.
12. Manheimer E and Anderson D "Survey of public information about ongoing clinical trials funded by industry: evaluation of completeness and accessibility" BMJ 2002; 325: 528-531.
13. Zarin DA et al. "Issues in the registration of clinical trials" JAMA 2007; 297 (19): 2112-2120.
14. Zarin DA and Keselman A "Registering a clinical trial in clinicalTrials.gov" Chest 2007; 131 (3): 909-912.
15. ClinicalTrials.gov "Data Element Definitions (draft)" 5 February 2008. prsinfo.clinicaltrials.gov accessed 3 March 2008: 14 pages.
16. Hopewell S et al. "CONSORT for reporting randomized controlled trials in journal and conference abstracts: explanation and elaboration" PLoS Med 2008; 5 (1): e20.
17. ICH harmonized tripartite guideline "Structure and content of clinical sudy reports. E3" 30 November 1995. www.ich.org/LOB/media/ MEDIA479.pdf accessed 8 March 2007:49 pages.
18. Dickersin K and Rennie D "Registering clinical trials" JAMA 2003; 290 (4): 516-523.
19. Dyer O "GlaxoSmithKline faces US lawsuit over concealment of trial results" BMJ 2004; 328 (7453): 1395.
20. Rennie D "Trial registration: a great idea switches from ignored to irresistible" JAMA 2004; 292 (11): 1359-1362.
21. International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) et al. "Joint position on the disclosure of clinical trial information via clinical trial registries and databases" 6 January 2005: 3 pages.
22. Damle A et al. "A Policy Study of Clinical Trial Registries and Results Databases". Public Citizen's Health Research Group 2007:12 pages.
23. International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) "International Clinical Trials Registry Platform. IFPMA comments on Ictrp consultation on delayed disclosure" January 2006:6 pages.
24. Goodyear M "Closing the Gaps: Moving Closer to a Collaborative Culture. Comments on Disclosure Timing: Balancing increased transparency and competitive advantage." Submission to WHO International Clinical Trials Registry Platform, March 2006: 9 pages.
25. Burgermeister J "New EU trials database is criticised for lack of openness" BMJ 2004; 328 (7448): 1094.
26. European Medicines Agency "Statistics archive 2007" Novembre 2007. eudract.emea.europa.eu accessed 7 March 2007: 1 page.
27. Commission of the European Communities "Draft. Guidance on the information concerning paediatric clinical trials to be entered into the EU Data base on Clinical Trials (EudraCT) and on the information to be made public by the European Medicines Agency (EMEA), in accordance with Article 41 of Regulation No. (EC) 1901/2006" version du 20 February 2008. ec.europa.eu accessed 16 April 2008: 9 pages.
28. Savulescu J et al. "Are research ethics committees behaving unethically? Some suggestions for improving performance and accountability" BMJ 1996; 313 (7069): 1390-1393.
29. The World Medical Association "Declaration of Helsinki. Ethical Principles for Medical Research Involving Human Subjects". www.wma.net/ e/policy/b3.htm accessed 7 March 2008:6 pages.